Have a feature idea you'd love to see implemented? Let us know!

ILMN Illumina Inc

Price (delayed)

$94.2

Market cap

$14.92B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.69

Enterprise value

$16.34B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
The gross margin has grown by 7% YoY and by 2.3% from the previous quarter
The company's gross profit rose by 4.3% YoY
The equity has plunged by 59% YoY but it has increased by 12% from the previous quarter
The quick ratio has contracted by 25% from the previous quarter but it has grown by 11% YoY
Illumina's revenue has decreased by 2.9% YoY

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
158.4M
Market cap
$14.92B
Enterprise value
$16.34B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.3
Price to sales (P/S)
3.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.74
Earnings
Revenue
$4.37B
Gross profit
$2.86B
Operating income
-$833M
Net income
-$1.22B
EBIT
-$1.08B
EBITDA
-$725M
Free cash flow
$709M
Per share
EPS
-$7.69
EPS diluted
-$7.69
Free cash flow per share
$4.46
Book value per share
$14.96
Revenue per share
$27.5
TBVPS
$30.79
Balance sheet
Total assets
$6.3B
Total liabilities
$3.93B
Debt
$2.54B
Equity
$2.37B
Working capital
$1.2B
Liquidity
Debt to equity
1.07
Current ratio
1.78
Quick ratio
1.26
Net debt/EBITDA
-1.95
Margins
EBITDA margin
-16.6%
Gross margin
65.4%
Net margin
-28%
Operating margin
-19.1%
Efficiency
Return on assets
-17.2%
Return on equity
-41.9%
Return on invested capital
-23%
Return on capital employed
-22.7%
Return on sales
-24.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
-3.09%
1 week
-6.03%
1 month
-33.34%
1 year
-30.94%
YTD
-29.51%
QTD
-29.51%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.37B
Gross profit
$2.86B
Operating income
-$833M
Net income
-$1.22B
Gross margin
65.4%
Net margin
-28%
The operating income has increased by 29% from the previous quarter and by 22% YoY
Illumina's operating margin has increased by 28% from the previous quarter and by 19% YoY
ILMN's net income is up by 23% since the previous quarter but it is down by 5% year-on-year
Illumina's net margin has increased by 22% QoQ but it has decreased by 9% YoY

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
N/A
P/B
6.3
P/S
3.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.74
Illumina's EPS has increased by 23% QoQ but it has decreased by 4.8% YoY
The equity has plunged by 59% YoY but it has increased by 12% from the previous quarter
The price to book (P/B) is 26% lower than the last 4 quarters average of 8.5 and 14% lower than the 5-year quarterly average of 7.3
ILMN's P/S is 64% below its 5-year quarterly average of 9.6 and 25% below its last 4 quarters average of 4.6
Illumina's revenue has decreased by 2.9% YoY

Efficiency

How efficient is Illumina business performance
The ROE has plunged by 124% YoY
The company's return on assets has shrunk by 62% YoY but it rose by 12% QoQ
ILMN's return on invested capital is up by 28% since the previous quarter and by 3% year-on-year
Illumina's return on sales has increased by 25% QoQ but it has decreased by 7% YoY

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 60% more than the total liabilities
The total assets has contracted by 38% YoY but it has grown by 4.8% from the previous quarter
The current ratio has contracted by 27% from the previous quarter but it has grown by 7% YoY
Illumina's debt is 7% higher than its equity
The debt to equity has soared by 182% year-on-year but it is down by 12% since the previous quarter
The equity has plunged by 59% YoY but it has increased by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.